Adam Taich

CIK: 0001971187

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)9 (75.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (25.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

TXG

10x Genomics, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (12 total)

TXG
10x Genomics, Inc.
Sep 9, 2026
Sale(S)
Direct
13.8K shares at avg. $65.26$898K
TXG
10x Genomics, Inc.
Sep 9, 2026
Sale(S)
Direct
31.4K shares at avg. $64.31$2.0M
TXG
10x Genomics, Inc.
Sep 9, 2026
Sale(S)
Direct
1.2K shares at avg. $63.68$77K
TXG
10x Genomics, Inc.
Aug 24, 2026
Sale(S)
Direct
17.2K shares at avg. $63.02$1.1M
TXG
10x Genomics, Inc.
May 22, 2026
Sale(S)
Direct
15.1K shares at avg. $24.44$369K
TXG
10x Genomics, Inc.
Feb 26, 2026
Award(A)
Direct
106.6K shares-
TXG
10x Genomics, Inc.
Feb 23, 2026
Sale(S)
Direct
9K shares at avg. $18.58$167K
TXG
10x Genomics, Inc.
Nov 24, 2025
Sale(S)
Direct
11.9K shares at avg. $19.00$226K
TXG
10x Genomics, Inc.
Aug 22, 2025
Sale(S)
Direct
22.3K shares at avg. $13.79$308K
TXG
10x Genomics, Inc.
May 22, 2025
Sale(S)
Direct
4K shares at avg. $8.30$34K
TXG
10x Genomics, Inc.
Mar 17, 2025
Award(A)
Direct
133.9K shares-
TXG
10x Genomics, Inc.
Oct 23, 2024
Award(A)
Direct
201.7K shares-

		Type	Shares	Price		Ownership
Sep 9, 2026	TXG 10x Genomics, Inc.	Sale(S)	13,754	$65.26	$897,550	Direct
Sep 9, 2026	TXG 10x Genomics, Inc.	Sale(S)	31,428	$64.31	$2,021,125	Direct
Sep 9, 2026	TXG 10x Genomics, Inc.	Sale(S)	1,206	$63.68	$76,795	Direct
Aug 24, 2026	TXG 10x Genomics, Inc.	Sale(S)	17,166	$63.02	$1,081,853	Direct
May 22, 2026	TXG 10x Genomics, Inc.	Sale(S)	15,098	$24.44	$369,018	Direct
Feb 26, 2026	TXG 10x Genomics, Inc.	Award(A)	106,579	-	$0	Direct
Feb 23, 2026	TXG 10x Genomics, Inc.	Sale(S)	8,968	$18.58	$166,593	Direct
Nov 24, 2025	TXG 10x Genomics, Inc.	Sale(S)	11,888	$19.00	$225,852	Direct
Aug 22, 2025	TXG 10x Genomics, Inc.	Sale(S)	22,315	$13.79	$307,657	Direct
May 22, 2025	TXG 10x Genomics, Inc.	Sale(S)	4,044	$8.30	$33,562	Direct
Mar 17, 2025	TXG 10x Genomics, Inc.	Award(A)	133,928	-	-	Direct
Oct 23, 2024	TXG 10x Genomics, Inc.	Award(A)	201,704	-	-	Direct

1-12 of 12 transactions

About Taich Adam

Taich Adam (SEC CIK 0001971187) files insider reports with the SEC as Chief Financial Officer of 10x Genomics, Inc. (TXG).

Signal8 holds 9 ownership filings by Taich Adam, all Form 4s, filed between Mar 19, 2025 and Sep 11, 2026. Those filings report 12 transactions, from Oct 23, 2024 to Sep 9, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Taich Adam's filings is in PLEASANTON, CA.

Recent filings by Taich Adam

Sep 9, 2026: Open-market sales of TXG shares (3 lines, Form 4, code S).
Aug 24, 2026: Open-market sale of TXG shares (Form 4, code S).
May 22, 2026: Open-market sale of TXG shares (Form 4, code S).
Feb 26, 2026: Grant or award of TXG shares (Form 4, code A).
Feb 23, 2026: Open-market sale of TXG shares (Form 4, code S).

Other insiders filing for 10x Genomics, Inc. (TXG)

SULIMAN SHEHNAAZ, Director
Saxonov Serge, Chief Executive Officer
STUELPNAGEL JOHN R, Director
Hindson Benjamin J.
Teichmann Sarah A., Director
Popovits Kimberly J, Director

How to read Form 4 transaction codes